Table: Aska Pharmaceutical - 6-MTH group results

ASKA Pharmaceutical Holdings

05/11/2019 06:00

Nov 5 (Reuters)- 
             Aska Pharmaceutical Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 6 months ended      6 months ended       Year to 
                Sep 30, 2019        Sep 30, 2018     Mar 31, 2020 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             26.58               23.48            53.00    
                 (+13.2 pct)         (-6.3 pct)       (+13.5 pct) 
  Operating        746 mln             960 mln            2.00    
                 (-22.3 pct)         (-48.7 pct)      (+12.2 pct) 
  Recurring        869 mln               1.08             2.10    
                 (-19.3 pct)         (-45.9 pct)      (+6.1 pct)  
  Net              577 mln             743 mln            1.00    
                 (-22.4 pct)         (-54.7 pct)      (-42.7 pct) 
  EPS             20.42 yen           26.36 yen        35.41 yen  
  Ann Div                             14.00 yen        14.00 yen  
  -Q2 div         7.00 yen            7.00 yen                    
  -Q4 div                             7.00 yen         7.00 yen   
  
  NOTE - Aska Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4514.T